Bain Capital Life Sciences Investors, LLC's Net Worth

$0

Estimate Recalculated Jun 18, 2025 08:57PM EST

Who is Bain Capital Life Sciences Investors, LLC

Bain Capital Life Sciences Investors, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, MARINUS PHARMACEUTICALS INC, RAPID MICRO BIOSYSTEMS, INC., Arcutis Biotherapeutics, Inc., Replimune Group, Inc., Xilio Therapeutics, Inc., Annexon, Inc., Aptinyx Inc., Solid Biosciences Inc., NewAmsterdam Pharma Co N.V., SpringWorks Therapeutics, Inc., and Kyverna Therapeutics, Inc..

SEC CIK

Bain Capital Life Sciences Investors, LLC's CIK is 0001703031

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc

Investor
Updated Nov 21, 2019
Form 4
-23.87%
-1.75M
$22.03
-$38.55M
Nov 21, 2019
5.58M
Sale
Nov 19
Form 4
-17.92%
-1.60M
$12.50
-$20.00M
May 31, 2019
7.33M
Sale
May 29
Form 4
3,472.09%
8.68M
$5.10
-$797.50K
Dec 19, 2017
8.93M
Purchase
Dec 18
Form 3
Apr 13, 2017
Showing 4 results

MARINUS PHARMACEUTICALS INC

Investor
Updated Dec 19, 2017
Form 4
-24.24%
-1.27M
$7.88
-$10.02M
Dec 19, 2017
3.98M
Sale
Dec 15 - Dec 19
Form 3
Sep 28, 2017
5.25M
Showing 2 results

RAPID MICRO BIOSYSTEMS, INC.

Investor
Updated Jul 21, 2021
Form 4
-79.76%
-33.24M
$20.00
Jul 21, 2021
8.43M
Buy-Options
Jul 19
Form 3
Jul 14, 2021
Showing 2 results

Arcutis Biotherapeutics, Inc.

Investor
Updated Feb 06, 2020
Form 4
7.98%
294.12K
$17.00
Feb 06, 2020
3.98M
Purchase
Feb 04
Form 3
Jan 30, 2020
Showing 2 results

Replimune Group, Inc.

Investor
Updated Jul 26, 2018
Form 4
1,107.32%
2.60M
$15.00
Jul 26, 2018
2.84M
Purchase
Jul 24
Form 3
Jul 19, 2018
Showing 2 results

Xilio Therapeutics, Inc.

Investor
Updated Dec 10, 2021
Form 4
1.54%
42.47K
$9.66
$410.16K
Dec 10, 2021
2.81M
Purchase
Dec 08 - Dec 10
Form 3
Nov 05, 2021
2.76M
Showing 2 results

Annexon, Inc.

Investor
Updated May 30, 2023
Form 3
May 30, 2023
5.40M
Form 4
5.55%
300.00K
$2.13
$639.72K
May 30, 2023
5.70M
Purchase
May 25
Form 4
-87.05%
-21.79M
$17.00
Jul 28, 2020
3.24M
Buy-Options
Jul 28
Form 3
Jul 23, 2020
Showing 4 results

Aptinyx Inc.

Investor
Updated Oct 27, 2020
Form 4
59.97%
3.33M
$3.00
$10.00M
Oct 27, 2020
8.89M
Purchase
Oct 26
Form 3
Jan 16, 2020
5.56M
Showing 2 results

Solid Biosciences Inc.

Investor
Updated Jan 12, 2024
Form 4
28.88%
904.16K
$5.53
$5.00M
Jan 12, 2024
4.03M
Grant
Jan 11
Form 3
Dec 05, 2022
3.13M
Showing 2 results

NewAmsterdam Pharma Co N.V.

Investor
Updated Dec 29, 2023
Form 3
Dec 29, 2023
10.47M
Showing 1 results

SpringWorks Therapeutics, Inc.

Investor
Updated Aug 12, 2021
Form 4
-17.15%
-1.00M
$70.25
-$70.25M
Aug 12, 2021
4.83M
Sale
Aug 10
Form 4
-19.91%
-1.45M
$71.50
-$103.67M
Mar 11, 2021
5.83M
Sale
Mar 09
Form 4
2.10%
150.00K
$18.00
Sep 19, 2019
7.28M
Purchase
Sep 17
Form 3
Sep 12, 2019
Showing 4 results

Kyverna Therapeutics, Inc.

Investor
Updated Feb 14, 2024
Form 4
-74.38%
-9.19M
$22.00
Feb 14, 2024
3.16M
Buy-Options
Feb 12
Form 3
Feb 07, 2024
Showing 2 results